Literature DB >> 15766274

Equilibrium and kinetic analysis of the unusual binding behavior of a highly immunogenic gluten peptide to HLA-DQ2.

Jiang Xia1, Ludvig M Sollid, Chaitan Khosla.   

Abstract

HLA-DQ2 predisposes an individual to celiac sprue by presenting peptides from dietary gluten to intestinal CD4(+) T cells. A selectively deamidated multivalent peptide from gluten (LQLQPFPQPELPYPQPELPYPQPELPYPQPQPF; underlined residues correspond to posttranslational Q --> E alterations) is a potent trigger of DQ2 restricted T cell proliferation. Here we report equilibrium and kinetic measurements of interactions between DQ2 and (i) this highly immunogenic multivalent peptide, (ii) its individual constituent epitopes, (iii) its nondeamidated precursor, and (iv) a reference high-affinity ligand of HLA-DQ2 that is not recognized by gluten-responsive T cells from celiac sprue patients. The deamidated 33-mer peptide efficiently exchanges with a preloaded peptide in the DQ2 ligand-binding groove at pH 5.5 as well as pH 7.3, suggesting that the peptide can be presented to T cells comparably well through the endocytic pathway or via direct loading onto extracellular HLA-DQ2. In contrast, the monovalent peptides, and the nondeamidated precursor, as well as the tight-binding reference peptide show a much poorer ability to exchange with a preloaded peptide in the DQ2 binding pocket, especially at pH 7.3, suggesting that endocytosis of these peptides is a prerequisite for T cell presentation. At pH 5.5 and 7.3, dissociation of the deamidated 33-mer peptide from DQ2 is much slower than dissociation of its constituent monovalent epitopes or the nondeamidated precursor but faster than dissociation of the reference high-affinity peptide. Oligomeric states involving multiple copies of the DQ2 heterodimer bound to a single copy of the multivalent 33-mer peptide are not observed. Together, these results suggest that the remarkable antigenicity of the 33-mer gluten peptide is primarily due to its unusually efficient ability to displace existing ligands in the HLA-DQ2 binding pocket, rather than an extremely low rate of dissociation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15766274     DOI: 10.1021/bi047747c

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

Review 1.  Recent advances in coeliac disease.

Authors:  D A van Heel; J West
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

2.  Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease.

Authors:  Jiang Xia; Elin Bergseng; Burkhard Fleckenstein; Matthew Siegel; Chu-Young Kim; Chaitan Khosla; Ludvig M Sollid
Journal:  Bioorg Med Chem       Date:  2007-07-25       Impact factor: 3.641

3.  How T cells taste gluten in celiac disease.

Authors:  Bana Jabri; Xi Chen; Ludvig M Sollid
Journal:  Nat Struct Mol Biol       Date:  2014-04-28       Impact factor: 15.369

4.  Oral enzyme therapy for celiac sprue.

Authors:  Michael T Bethune; Chaitan Khosla
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

5.  Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.

Authors:  Lu Shan; Shuo-Wang Qiao; Helene Arentz-Hansen; Øyvind Molberg; Gary M Gray; Ludvig M Sollid; Chaitan Khosla
Journal:  J Proteome Res       Date:  2005 Sep-Oct       Impact factor: 4.466

Review 6.  Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders.

Authors:  Ludvig M Sollid; Bana Jabri
Journal:  Curr Opin Immunol       Date:  2011-09-12       Impact factor: 7.486

7.  Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides.

Authors:  Michael T Bethune; Matthew Siegel; Samuel Howles-Banerji; Chaitan Khosla
Journal:  J Pharmacol Exp Ther       Date:  2009-02-13       Impact factor: 4.030

8.  Noninflammatory gluten peptide analogs as biomarkers for celiac sprue.

Authors:  Michael T Bethune; Mónica Crespo-Bosque; Elin Bergseng; Kaushiki Mazumdar; Lara Doyle; Karol Sestak; Ludvig M Sollid; Chaitan Khosla
Journal:  Chem Biol       Date:  2009-08-28

9.  Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.

Authors:  Matthew Siegel; Jiang Xia; Chaitan Khosla
Journal:  Bioorg Med Chem       Date:  2007-06-13       Impact factor: 3.641

10.  A food-grade enzyme preparation with modest gluten detoxification properties.

Authors:  Jennifer Ehren; Belen Morón; Edith Martin; Michael T Bethune; Gary M Gray; Chaitan Khosla
Journal:  PLoS One       Date:  2009-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.